Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); Raising Numbers on Recent Progress in HCV
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $139.17 +0.59%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on Gilead Sciences (NASDAQ: GILD) price target raised from $54 to $56.
Analyst, Alan Carr, said, "Gilead reported $2.28B (+18.5% y/y) in total revenues yesterday, above our and consensus expectations for $2.16B and $2.20B, respectively. Non-GAAP EPS of $0.91 (+4.7% y/y) exceeded our $0.88 estimate, but was under consensus $0.93. We reiterate our rating and are raising our price target based in part on encouraging progress in HCV reported at the recent EASL meeting."
FY12 EPS estimate increased from $3.68 to $3.79 and FY13 from $4.18 to $4.41.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $52.72 yesterday.
Analyst, Alan Carr, said, "Gilead reported $2.28B (+18.5% y/y) in total revenues yesterday, above our and consensus expectations for $2.16B and $2.20B, respectively. Non-GAAP EPS of $0.91 (+4.7% y/y) exceeded our $0.88 estimate, but was under consensus $0.93. We reiterate our rating and are raising our price target based in part on encouraging progress in HCV reported at the recent EASL meeting."
FY12 EPS estimate increased from $3.68 to $3.79 and FY13 from $4.18 to $4.41.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $52.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- Menicon (7780:JP) PT Raised to JPY2,400 at Nomura/Instinet
- Deutsche Bank Downgrades SentinelOne Inc (S) to Hold on Valuation
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
